Aequim Alternative Investments »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Aequim Alternative Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Aequim Alternative Investments from 13F filings

Historical chart of Aequim Alternative Investments investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Aequim Alternative Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Aequim Alternative Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $40M 41M 0.99
2023-09-30 $28M 30M 0.93

More positions owned by Aequim Alternative Investments

Occidental Pete Corp *w Exp 08/03/202 (OXY.WS)
Chesapeake Energy Corp *w Exp 02/09/202 (CHKEW)
Chesapeake Energy Corp *w Exp 02/09/202 (CHKEZ)
Snap Note 0.250% 5/0 (Principal)
Zillow Group Note 0.750% 9/0 (Principal)
Nice Sys Note 1.250% 1/1 (Principal)
Chesapeake Energy Corp *w Exp 02/09/202 (CHKEL)
Etsy Note 0.125%10/0 (Principal)
Akamai Technologies Note 0.125% 5/0 (Principal)
Peloton Interactive Note 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Datadog Note 0.125% 6/1 (Principal)
Spotify Usa Note 3/1 (Principal)
Cnx Resources Corporation (CNX)
Splunk Note 1.125% 6/1 (Principal)

View all positions for Aequim Alternative Investments

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Calamos Advisors
Steelhead Partners
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1